Boston Medical Sciences
3 known investors
The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan. The solution aims to overcome patient resistance to traditional colonoscopy screening by offering a high-accuracy examination without laxative preparation.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Investors · 3
In the news
- Boston Medical Sciences, developer of laxative-free virtual endoscopy system, raises additional $9.3 millionitbusinesstoday.com · 2025
- Boston Medical Sciences Raises 930 Million Yen in Series A – BRIDGEthebridge.jp · 2025
- Boston Medical Sciences - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2023